Additional findings supporting this mechanism included reduced colon tumor formation in muscarinic agonist-treated mice lacking intestinal epithelial cell βPix expression and reduced MYC, CCND1 and PTGS2 gene and protein expression in colon adenocarcinomas resected from those mice (Cheng et al., 2023). Here, PTGS2 is linked to colonic neoplasm.